Related Experiment Video
Updated: Apr 20, 2026
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Genetics of familial melanoma: 20 years after CDKN2A
Lauren G Aoude1, Karin A W Wadt, Antonia L Pritchard
1QIMR Berghofer Medical Research Institute, Brisbane, Qld, Australia; University of Queensland, Brisbane, Qld, Australia.
Abstract:
Twenty years ago, the first familial melanoma susceptibility gene, CDKN2A, was identified. Two years later, another high-penetrance gene, CDK4, was found to be responsible for melanoma development in some families. Progress in identifying new familial melanoma genes was subsequently slow; however, with the advent of next-generation sequencing, a small number of new high-penetrance genes have recently been uncovered. This approach has identified the lineage-specific oncogene MITF as a susceptibility gene both in melanoma families and in the general population, as well as the discovery of telomere maintenance as a key pathway underlying melanoma predisposition. Given these rapid recent advances, this approach seems likely to continue to pay dividends. Here, we review the currently known familial melanoma genes, providing evidence that most additionally confer risk to other cancers, indicating that they are likely general tumour suppressor genes or oncogenes, which has significant implications for surveillance and screening.
Insights
Familial melanoma susceptibility genes like CDKN2A and CDK4 were found decades ago. Recent advances in sequencing have identified new genes, such as MITF, and pathways like telomere maintenance, improving melanoma risk understanding.
Area of Science:
- Genetics
- Oncology
- Dermatology
Background:
- The first familial melanoma susceptibility gene, CDKN2A, was identified 20 years ago, followed by CDK4 two years later.
- Progress in identifying new familial melanoma genes was slow until the advent of next-generation sequencing (NGS).
Purpose of the Study:
- To review currently known familial melanoma genes.
- To discuss recent advances in identifying melanoma susceptibility genes using NGS.
- To highlight the implications of these genes for other cancers and patient surveillance.
Main Methods:
- Review of existing literature on familial melanoma genes.
- Analysis of recent studies utilizing next-generation sequencing for gene discovery.
- Examination of evidence linking familial melanoma genes to other cancer types.
Main Results:
- NGS has led to the identification of new high-penetrance genes, including the oncogene MITF.
- Telomere maintenance has been identified as a key pathway in melanoma predisposition.
- Most identified familial melanoma genes also confer risk for other cancers, suggesting they are general tumor suppressor genes or oncogenes.
Conclusions:
- Recent advances in sequencing technology are rapidly expanding the understanding of melanoma genetics.
- Familial melanoma genes have broader implications, acting as general tumor suppressors or oncogenes.
- These findings have significant implications for cancer surveillance and screening strategies in at-risk individuals.
Related Concept Videos
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:21Cancers Originate from Somatic Mutations in a Single Cell
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
02:15M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...